The primary objective of this review is to offer a consolidated understanding of the role of the long non-coding RNA SNHG6 in relation to various clinicopathological parameters observed in cancers; by examining existing literature, this review seeks to shed light on the biogenesis, regulatory mechanisms, and the overarching influence of SNHG6 in dictating the hallmarks of cancer. This evidence concerns the gene SNHG6 and cancer.